%0 Clinical Trial, Phase I
%T Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal Disease: A Phase 1 Nonrandomized Controlled Trial.
%A Ahmed KA
%A Kumthekar PU
%A Pina Y
%A Kim Y
%A Vogelbaum MA
%A Han HS
%A Forsyth PA
%J JAMA Oncol
%V 10
%N 7
%D 2024 Jul 1
%M 38780965
%F 33.006
%R 10.1001/jamaoncol.2024.1299
%X This nonrandomized controlled trial examines the safety of radiation therapy (RT) followed by intrathecal trastuzumab and pertuzumab for patients with ERBB2-positive breast leptomeningeal disease (LMD).